Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2847075 | 1.00 | MEN1 (0.33) | MEN1ALDH1A1CYP1A2THRBKMT2A | |
| SCHEMBL11857824 | 0.88 | GRIK1 (0.32) | ALDH1A1 | |
| SCHEMBL11857840 | 0.88 | GRIK1 (0.32) | ALDH1A1 | |
| SCHEMBL2843457 | 0.86 | PTPN1 (0.33) | — | |
| SCHEMBL2843461 | 0.86 | PTPN1 (0.33) | — | |
| SCHEMBL3270986 | 0.82 | ALDH1A1 (0.38) | MEN1ALDH1A1KMT2A | |
| SCHEMBL5607918 | 0.78 | TSHR (0.32) | ALDH1A1 | |
| SCHEMBL5607911 | 0.78 | TSHR (0.32) | ALDH1A1 | |
| SCHEMBL9049415 | 0.77 | TSHR (0.41) | MEN1ALDH1A1CYP1A2THRBKMT2A | |
| SCHEMBL9049411 | 0.77 | TSHR (0.41) | MEN1ALDH1A1CYP1A2THRBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100160670-A1 | NOVEL PROCESS FOR THE PREPARATION OF CHIRAL COMPOUNDS DERIVED FROM HEXANOIC ACID ESTERS AND INTERMEDIATES USED IN THE SYNTHESIS OF CHIRAL-2-(BROMOMETHYL)-2-ETHYLHEXANOIC ACID | AVENTIS PHARMA S.A. (FR) | 2010-06-24 | — | — | US | disclosed |
| US-20090163737-A1 | NOVEL PROCESS FOR THE PREPARATION OF CHIRAL COMPOUNDS DERIVED FROM HEXANOIC ACID ESTERS AND INTERMEDIATES USED IN THE SYNTHESIS OF CHIRAL 2-(BROMOMETHYL)-2-ETHYLHEXANOIC ACID | AVENTIS PHARMA S.A. (FR) | 2009-06-25 | — | — | US | disclosed |
| US-20080108847-A1 | NOVEL PROCESS FOR THE PREPARATION OF CHIRAL COMPOUNDS DERIVED FROM HEXANOIC ACID ESTERS AND INTERMEDIATES USED IN THE SYNTHESIS OF CHIRAL2-(BROMOMETHYL)-2-ETHYLHEXANOIC ACID | AVENTIS PHARMA S.A. (FR) | 2008-05-08 | — | — | US | disclosed |
| US-20040147774-A1 | Novel chiral compounds derived from hexanoic acid esters, preparation process and intermediates, use in the synthesis of chiral 2-(bromomethyl)-2-ethylhexanoic acid | AVENTIS PHARMA S.A. (FR) | 2004-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080108847-A1 | NOVEL PROCESS FOR THE PREPARATION OF CHIRAL COMPOUNDS DERIVED FROM HEXANOIC ACID ESTERS AND INTERMEDIATES USED IN THE SYNTHESIS OF CHIRAL2-(BROMOMETHYL)-2-ETHYLHEXANOIC ACID | HCAR2, HCAR3, HCAR1 | MEN1 4067/4885ALDH1A1 196/4885CYP1A2 31/4885 |
| US-20090163737-A1 | NOVEL PROCESS FOR THE PREPARATION OF CHIRAL COMPOUNDS DERIVED FROM HEXANOIC ACID ESTERS AND INTERMEDIATES USED IN THE SYNTHESIS OF CHIRAL 2-(BROMOMETHYL)-2-ETHYLHEXANOIC ACID | HCAR3, HCAR2, HCAR1 | MEN1 4171/4885ALDH1A1 163/4885CYP1A2 84/4885 |
| US-20040147774-A1 | Novel chiral compounds derived from hexanoic acid esters, preparation process and intermediates, use in the synthesis of chiral 2-(bromomethyl)-2-ethylhexanoic acid | HCAR2, FFAR2, HCAR3 | MEN1 3949/4885ALDH1A1 128/4885CYP1A2 103/4885 |
| US-20100160670-A1 | NOVEL PROCESS FOR THE PREPARATION OF CHIRAL COMPOUNDS DERIVED FROM HEXANOIC ACID ESTERS AND INTERMEDIATES USED IN THE SYNTHESIS OF CHIRAL-2-(BROMOMETHYL)-2-ETHYLHEXANOIC ACID | HCAR2, HCAR3, HCAR1 | MEN1 4138/4885ALDH1A1 160/4885CYP1A2 74/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.